CoChat

Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty?

Magruder, Matthew L., Yao, Vincent J.H., Rodriguez, Ariel N., Ng, Mitchell K., Sasson, Victor, Erez, Orry · 2023 · The Journal of Arthroplasty
Cited by 106

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND Diabetes mellitus (DM) and obesity are associated with total knee arthroplasty (TKA) complications. Semaglutide, a medication for DM and weight loss, can potentially affect TKA outcomes. This study investigated whether Semaglutide use during TKA demonstrates fewer: 1) medical complications; 2) implant-related complications; 3) readmissions; and 4) costs. METHODS A retrospective query was performed using a National database to 2021. Patients undergoing TKA for osteoarthritis with DM and Semaglutide use were successfully propensity score-matched to controls (41,575 patients[Semaglutide=7,051; control=34,524]). Outcomes included 90-day post-operative medical complications, 2-year implant-related complications, 90-day readmissions, in-hospital lengths-of-stay, and day-of-surgery as well as 90-day episode-of-care costs. Multivariate logistical regressions calculated odds ratios (ORs), 95% confidence intervals, and P-values (P<0.003 as significance threshold after Bonferroni corrections). RESULTS Semaglutide cohorts had higher incidence and odds of myocardial infarction (MI)(1.0 vs 0.7%; OR 1.49; P=0.003), acute kidney injury (AKI)(4.9 vs 3.9%; OR 1.28; P<0.001), pneumonia (2.8 vs 1.7%; OR 1.67; P<0.001), and hypoglycemic events (1.9 vs 1.2%; OR 1.55; P<0.001), but lower odds of sepsis (0 vs 0.4%; OR 0.23; P<0.001). Semaglutide cohorts also had lower odds of prosthetic joint infections (PJI)(2.1 vs 3.0%; OR 0.70; P<0.001) and readmission (7.0 vs 9.4%; OR 0.71; P<0.001), and trended towards lower odds of revisions (4.0 vs 4.5%; OR 0.86; P=0.02) and 90-day costs ($15,291.66 vs $16,798.46; P=0.012). CONCLUSION Semaglutide use during TKA decreased risk for sepsis, PJI, and readmissions, but also increased risk for MI, AKI, pneumonia, and hypoglycemic events. Future studies should consider surgeon volume, patient socioeconomic status, anesthetic techniques, and Semaglutide dosage in analyses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.arth.2023.05.071

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 106

Metadata

Authors
Magruder, M. L., Yao, V. J. H., Rodriguez, A. N., Ng, M. K., Sasson, V., & Erez, O.
Venue
The Journal of Arthroplasty
Publisher
Elsevier BV
Published
2023-11
Volume
38
Issue
11
Pages
2311-2315.e1
ISSN
0883-5403 (ISSN-L)
OpenAlex
W4379284628
Cited by
106
References
14
FWCI
25.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty? https://app.cochat.ai/papers/10.1016/j.arth.2023.05.071
The paper
Magruder, M. L., Yao, V. J. H., Rodriguez, A. N., Ng, M. K., Sasson, V., & Erez, O. (2023). Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty? The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2023.05.071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.